MAVYRET® Glecaprevir / Pibrentasvir 100 mg / 40 mg Tablet 84 Tablets

Name: HCV Protease inhibitor / HCV NS5A inhibitor
Brand: MAVYRET®

MAVYRET, TAB 3X28 100MG-40MG (84/EA)

McKesson #

1198027

Manufacturer #

00074262528

Brand

MAVYRET®

Manufacturer

AbbVie Inc

Country of Origin

Ireland

Application

HCV Protease inhibitor / HCV NS5A inhibitor

Buy American Act (BAA) Compliant

Container Type

Carton

Dosage Form

Tablet

Generic Drug Code

43699

Generic Drug Name

Glecaprevir / Pibrentasvir

NDC Number

00074262528

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Quantity

84 Tablets

Strength

100 mg / 40 mg

Trade Agreement Act (TAA) Compliant

Yes

UNSPSC Code

51343825

MAVYRET is a fixed-dose combination of glecaprevir, a hepatitis C virus (HCV) NS3/4A protease inhibitor, and pibrentasvir, an HCV NS5A inhibitor, and is indicated for the treatment of adult and pediatric patients 3 years and older with chronic HCV genotype (GT) 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A)
MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor, but not both